All posts by: Michael Zand

Hope and hype around cancer immunotherapy
CNN
While other treatment options — from targeted therapy to chemotherapy — still and will continue to play an important role in cancer research, immunotherapy simply expands the options and possibilities for patients, said Dr. Jeff Weber, medical …
The Potential of Immunotherapy for Mesothelioma | MAA CenterMesothelioma & Asbestos Awareness Center (blog)
Tip Sheet: Immunotherapy Trial Results for Cancer Among Research Presentations by Johns Hopkins ScientistsNewswise (press release)
Parker Institute for Cancer Immunotherapy Scientists to Present …PR Newswire (press release)
Japan Today –Business Wire (press release)
all 11 news articles »

Hope and hype around cancer immunotherapy
CNN
While other treatment options — from targeted therapy to chemotherapy — still and will continue to play an important role in cancer research, immunotherapy simply expands the options and possibilities for patients, said Dr. Jeff Weber, medical …
The Potential of Immunotherapy for Mesothelioma | MAA CenterMesothelioma & Asbestos Awareness Center (blog)
Tip Sheet: Immunotherapy Trial Results for Cancer Among Research Presentations by Johns Hopkins ScientistsNewswise (press release)
Parker Institute for Cancer Immunotherapy Scientists to Present …PR Newswire (press release)
Japan Today –Business Wire (press release)
all 11 news articles »

Hope and hype around cancer immunotherapy
CNN
Some hospitals and health care systems call it a “miracle in the making” and a “game-changer.” It’s a treatment approach that harnesses the body’s own immune system to target and attack a disease, such as cancer. Immunotherapy can come in many forms …
The Potential of Immunotherapy for MesotheliomaMesothelioma & Asbestos Awareness Center (blog)
Cancer Research Institute Hosts Fifth Annual Cancer Immunotherapy Month(tm) in June to Celebrate Progress in …Newswise (press release)
Parker Institute for Cancer Immunotherapy Scientists to Present Research at ASCO 2017 on IDO Pathway Inhibitors …PR Newswire (press release)
Japan Today –Business Wire (press release)
all 37 news articles »

Sangamo: Making Gains in Gene Therapy
Moneyshow.com (registration)
In a very competitive bidding process Sangamo Therapeutics (SGMO) has inked a significant global partnership with Pfizer (PFE), who brings a wealth of value to SGMO, and notably validates the latter company’s gene therapy platform, explains biotech …

Sangamo: Making Gains in Gene Therapy
Moneyshow.com (registration)
In a very competitive bidding process Sangamo Therapeutics (SGMO) has inked a significant global partnership with Pfizer (PFE), who brings a wealth of value to SGMO, and notably validates the latter company’s gene therapy platform, explains biotech …

Sangamo: Making Gains in Gene Therapy
Moneyshow.com (registration)
In a very competitive bidding process Sangamo Therapeutics (SGMO) has inked a significant global partnership with Pfizer (PFE), who brings a wealth of value to SGMO, and notably validates the latter company’s gene therapy platform, explains biotech …

Inovio Announces Clinical Trial Collaboration To Evaluate A Novel T-cell Immunotherapy In Combination With A PD-L1 …
Clinical Leader
The phase 1b/2 immuno-oncology trial will evaluate Genentech’s atezolizumab (TECENTRIQ®) in combination with Inovio’s INO-5401, a T cell activating immunotherapy encoding multiple antigens, and INO-9012, an immune activator encoding IL-12.

and more »